Search / Trial NCT06231420

Daily Step Count Using Pedometer for Sarcopenic Management in Patient With Cirrhosis: Randomized Controlled Trial

Launched by MAHIDOL UNIVERSITY · Jan 29, 2024

Trial Information

Current as of October 03, 2024

Enrolling by invitation

Keywords

Sarcopenia Liver Cirrhosis Daily Step Count Pedometer Recording

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * 1. Age 18 - 75 years old
  • * 2. Cirrhotic patient with diagnosed sarcopenia
  • * 3. Patients or caregiver who can write and announce Thai language
  • * 4. Cirrhotic patient who was post liver transplantation \> 1 year
  • Exclusion Criteria:
  • * 1. Cirrhosis Child-Turcotte-Pugh (CTP) C \> 10 2. Refractory ascites 3. Decompensated comorbidity: heart failure NYHA III-IV, ESRD with dialysis, COPD Gold D 4. Performance status ECOG 3-4 5. Bone fracture within 4 weeks or limitation of activity 6. Pregnancy and breastfeeding 7. HCC during treatment with TACE or microwave ablation or radiofrequency ablation within 6 months before enrollment 8. Advanced stage malignancy 9. Received chemotherapy 10. Muscle weakness disease 11. Recent cerebrovascular disease within 6 months and motor weakness grade \< II 12. Age 65-75 years old with history of falling \> 2 times/year

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Bangkok, , Thailand

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0